241 related articles for article (PubMed ID: 29216508)
1. Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer.
Zhang L; Chen B; Liu X; Song J; Fang M; Hu C; Dong D; Li W; Tian J
Transl Oncol; 2018 Feb; 11(1):94-101. PubMed ID: 29216508
[TBL] [Abstract][Full Text] [Related]
2. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
3. Value of pre-therapy
Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
[TBL] [Abstract][Full Text] [Related]
4. Clinical and radiological predictors of epidermal growth factor receptor mutation in nonsmall cell lung cancer.
Dang Y; Wang R; Qian K; Lu J; Zhang H; Zhang Y
J Appl Clin Med Phys; 2021 Jan; 22(1):271-280. PubMed ID: 33314737
[TBL] [Abstract][Full Text] [Related]
5. Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
Yang X; Fang C; Li C; Gong M; Yi X; Lin H; Li K; Yu X
Front Oncol; 2022; 12():904983. PubMed ID: 35875167
[TBL] [Abstract][Full Text] [Related]
6. CT-Based Radiomic Signature as a Prognostic Factor in Stage IV
Li H; Zhang R; Wang S; Fang M; Zhu Y; Hu Z; Dong D; Shi J; Tian J
Front Oncol; 2020; 10():57. PubMed ID: 32133282
[No Abstract] [Full Text] [Related]
7. Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With
Tang X; Li Y; Yan WF; Qian WL; Pang T; Gong YL; Yang ZG
Front Oncol; 2021; 11():719919. PubMed ID: 34660285
[TBL] [Abstract][Full Text] [Related]
8. Predicting EGFR mutation subtypes in lung adenocarcinoma using
Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
[TBL] [Abstract][Full Text] [Related]
9. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
[No Abstract] [Full Text] [Related]
10. Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy.
Weng Q; Hui J; Wang H; Lan C; Huang J; Zhao C; Zheng L; Fang S; Chen M; Lu C; Bao Y; Pang P; Xu M; Mao W; Wang Z; Tu J; Huang Y; Ji J
Front Oncol; 2021; 11():590937. PubMed ID: 34422624
[TBL] [Abstract][Full Text] [Related]
11. CT Radiomics Predict EGFR-T790M Resistance Mutation in Advanced Non-Small Cell Lung Cancer Patients After Progression on First-line EGFR-TKI.
Tang X; Li Y; Shen LT; Yan WF; Qian WL; Yang ZG
Acad Radiol; 2023 Nov; 30(11):2574-2587. PubMed ID: 36941156
[TBL] [Abstract][Full Text] [Related]
12. The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma.
Zhao W; Wu Y; Xu Y; Sun Y; Gao P; Tan M; Ma W; Li C; Jin L; Hua Y; Liu J; Li M
Front Oncol; 2019; 9():1485. PubMed ID: 31993370
[No Abstract] [Full Text] [Related]
13. Prediction of EGFR mutation status in lung adenocarcinoma based on
Tan JL; Xia L; Sun SG; Zeng H; Lu DY; Cheng XJ
Am J Nucl Med Mol Imaging; 2023; 13(5):230-244. PubMed ID: 38023818
[TBL] [Abstract][Full Text] [Related]
14. EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma.
Chen Q; Li Y; Cheng Q; Van Valkenburgh J; Sun X; Zheng C; Zhang R; Yuan R
Onco Targets Ther; 2022; 15():597-608. PubMed ID: 35669165
[TBL] [Abstract][Full Text] [Related]
15. Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.
Zhao HY; Su YX; Zhang LH; Fu P
Neoplasma; 2022 Jan; 69(1):233-241. PubMed ID: 34779641
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of novel radiomics-based nomograms for the prediction of
Dong Y; Jiang Z; Li C; Dong S; Zhang S; Lv Y; Sun F; Liu S
Quant Imaging Med Surg; 2022 May; 12(5):2658-2671. PubMed ID: 35502390
[TBL] [Abstract][Full Text] [Related]
17. Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT.
Jiang M; Zhang Y; Xu J; Ji M; Guo Y; Guo Y; Xiao J; Yao X; Shi H; Zeng M
Nucl Med Commun; 2019 Aug; 40(8):842-849. PubMed ID: 31290849
[TBL] [Abstract][Full Text] [Related]
18.
Yang B; Ji HS; Zhou CS; Dong H; Ma L; Ge YQ; Zhu CH; Tian JH; Zhang LJ; Zhu H; Lu GM
Transl Lung Cancer Res; 2020 Jun; 9(3):563-574. PubMed ID: 32676320
[TBL] [Abstract][Full Text] [Related]
19. Predictive Power of a Radiomic Signature Based on
Li X; Yin G; Zhang Y; Dai D; Liu J; Chen P; Zhu L; Ma W; Xu W
Front Oncol; 2019; 9():1062. PubMed ID: 31681597
[TBL] [Abstract][Full Text] [Related]
20. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]